Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

Abstract Background Cardiac sarcoidosis (CS) is a rare but potentially life-threatening disease that causes conduction disturbance, systolic dysfunction, and, most notably, sudden cardiac death. 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) plays important ro...

Full description

Bibliographic Details
Main Authors: Sho Furuya, Osamu Manabe, Hiroshi Ohira, Kenji Hirata, Tadao Aikawa, Masanao Naya, Ichizo Tsujino, Kazuhiro Koyanagawa, Toshihisa Anzai, Noriko Oyama-Manabe, Tohru Shiga
Format: Article
Language:English
Published: SpringerOpen 2018-10-01
Series:EJNMMI Research
Subjects:
Cardiac sarcoidosis
18F-Fluorodeoxyglucose
PET
Metabolic cardiac volume
Steroid therapy
Online Access:http://link.springer.com/article/10.1186/s13550-018-0447-8

Internet

http://link.springer.com/article/10.1186/s13550-018-0447-8

Similar Items